drugset / Trial / NCT00044798

Magnetic Stimulation Therapy for Treating Vascular Depression

NCT00044798

RandomizedParallel-groupTriple-blindTreatment

Summary

This 12-week study will evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) of the brain, followed by citalopram (Celexa®), for treatment of depression associated with small vascular lesions in the brain (vascular depression).

Timeline

Start
2001-09
Primary completion
2007-03
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Background Citalopram Small molecule

Indications